With Match Week at a close, I wanted celebrate my wonderful fiancée @nadjellaoopamen and our successful Couple’s Match.
Navigating this cycle with her after going unmatched in 2021 has been an enormous feat of love and teamwork.
1/🧵
#Match2022#MatchAResident#MedTwitter
I try to remind med students and practicing physicians who consider scaling back or giving up clinical careers for content creation how unstable it can be. People view content creation as freedom. You can work for yourself on your own schedule. That's true to a certain degree, but keep in mind that you don't own your audience. TikTok owns it. YouTube owns it. One change in the algorithm could significantly impact your livelihood. A few years ago, YT reclassified shorts as videos that are under 3 minutes instead of 60 seconds. Overnight, my social media income was cut in half. It didn't matter too much to me, because I still work full time as an ophthalmologist.
I know I shit on the healthcare system and point out all the terrible things we deal with as physicians, but for all its faults, practicing medicine is an incredibly stable career, much more stable than content creation.
I will never begrudge anybody for pursuing their passions. Some people just can't practice medicine anymore, and are looking for any way out they can find. Content creation is a way out, and hardworking, talented people will make it happen. I just want people to know the grass isn't always greener...
#CardioNugget
The term “Type 2 NSTEMI” is not officially used anymore in formal definitions. Instead, the correct terminology is:
✅ Type 2 MI
This refers to myocardial infarction due to an imbalance between oxygen supply and demand not caused by a primary coronary event (e.g., vasospasm, anemia, tachyarrhythmia, hypotension). It can present with or without ST-elevation on ECG.
Quick refresher from the Fourth Universal Definition of MI:
-Type 1 MI: Plaque rupture with thrombus.
-Type 2 MI: Supply-demand mismatch causing ischemia not due to atherothrombosis.
#CardioNuggets #MedEd #CardioTwitter
Honey, stop what you're doing, new hyponatremia research just dropped!
What's it say?
It looks like slow correction is associated with worse outcomes, like death and length of stay!
Was it just a small study?
No, it was a meta-analysis of almost 12,000 patients!
https://t.co/FkVXCEWhxi
After surgical implantation of a bioprosthetic valve, obtain a TTE at 5 years, 10 years, and then annually--even without a clinical change (Class IIa). At/after 10 years, the incidence of clinically significant valve dysfunction increases substantially.
#CVBoardPearl#MedX
Med students doing interviews!
I recommend making 2-4 bullet points for:
- Tell me about yourself
- Why this specialty
- Why our program
- Where do you see yourself in 5/10/20 years
Even if you panic, it's easy to recall a few bullets to get back on track.
🔑 Tachycardia-induced cardiomyopathy is characterized by a dilated CM w/ moderate to severe biventricular systolic dysfunction and lack of hypertrophy. Mitral insufficiency may be present.
Read more key points from a state-of-the-art review on AiCM: https://t.co/qHKGtqWeF1
Needless to say technically difficult study (user dependent 😂). But taking every opportunity I can to learn bedside echos. #CardioTwitter
Appreciate tips on getting better views/resolutions?
8. PREVENT Trial: In patients with non-flow-limiting vulnerable coronary plaques, preventive PCI reduced major adverse CV events arising from high-risk vulnerable plaques, compared with optimal medical therapy alone.
5. STEP-HFpEF DM Trial: Among patients with obesity-related HFpEF and T2DM, semaglutide led to larger reductions in HF–related symptoms and physical limitations and greater weight loss than placebo at 1 year.
The PREVENT trial showed that preventive #PCI of focal non-FFR-positive plaques that are angiographically >50% & have evidence of vulnerability on intravascular imaging along w/ OMT is superior to OMT for clinical outcomes at 2 years.
Read more: https://t.co/vmsq7FRdYH
#ACC24
Obligatory post. First time feels here at #acc24. Such a great opportunity to be here with vast learning and stellar people. Hope to be back at next year’s meeting!